Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group

Cancer

Volumn 60, Issue 6, 1987, Pages 1178-1183

  Jacobs, Charlotte ^a,b   Goffinet, Don R ^b   Goffinet, Linda ^a,b   Kohler, Marsha ^b,c   Fee, Willard E ^d  

^a VA Puget Sound Hlth Care Syst S   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Otolaryngology and Head and Neck Surgery   (United States)

^d Northern California Oncology Group ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSIS; ENDOSCOPY; HEAD AND NECK CANCER; HUMAN; LARYNX; MOUTH; PHARYNX; THERAPY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY DOSAGE; RANDOM ALLOCATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023640054     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19870915)60:6<1178::AID-CNCR2820600604>3.0.CO;2-S     Document Type: Article

References (18)

1. Combination of radiotherapy and surgery in the treatment of head and neck cancer
2. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers
3. Evaluation of randomized preoperative and postoperative radiation therapy for supraglottic carcinoma
4. Carcinoma of the hypopharynx: Success and failure
5. Changing role of chemotherapy in the treatment of head and neck cancer
6. Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: A review
7. Current concepts: Chemotherapy in head and neck cancer
8. Combination therapy of advanced head and neck cancer: Induction of remissions with diamminedichloroplatinum (II) bleomycin and radiation therapy
9. Induction chemotherapy in advanced squamous head and neck carcinoma with high‐dose cis‐platinum and bleomycin infusion
10. Advanced squamous carcinoma of the head and neck: A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate
11. Adjuvant chemotherapy with cisdiaminedichloroplatinum II and 120‐hour infusion 5‐fluorouracil in Stage III and IV squamous cell carcinomas of the head and neck
12. A randomized trial of adjuvant chemotherapy in head and neck cancer
13. Cisplatin and bleomycin adjuvant chemotherapy in head and neck carcinomas
14. Non‐parametric estimation from incomplete observations
15. Fluorouracil cardiotoxicity
16. Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5‐fluorouracil before definitive therapy for locally advanced head and cancer
17. Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma: The Head and Neck Contracts Program